The Council for Responsible Nutrition or CRN, has officially submitted a Citizen’s Petition(1) to the Food and Drug Administration to establish a way for companies for marketing CBD products. As of right now, there is no way for hemp-derived cannabidiol or CBD product to be market either online or in any way to the public. This has caused many businesses to ignore CBD product marketing besides having posters outside the store they are housed in.
The petition also goes into how Congress, over a year ago, removed hemp and cannabis from the Federal Controlled Substance Act. The CBD products that are now off the Federal Controlled Substance Act as long as they do not have delta-9 tetrahydrocannabinol, also known as THC, the concentration of more than 0.3 percent on a dry weight basis.
Steve Minster, who is the president and CEO, said in the release, “Over one year has passed since FDA held its public meeting to understand better hemp-derived substances, including CBD, and how they should be regulated. During this time, consumer interest has grown, sales have increased, and product innovation has expanded, all while FDA has taken no substantial steps towards legalizing the ingredient. CRN is disappointed in FDA’s lack of forward movement with respect to regulating CBD, as we have called on the agency repeatedly to address this regulatory gap. With this Citizen’s Petition, CRN is urging the agency to take action by providing a legal pathway to market for responsible companies, to enforce existing dietary supplement requirements for companies already marketing CBD as dietary supplements, and above all else, to ensure consumer safety to the 20 million Americans who take CBD dietary supplements.” This quote showcases how the CBD is gaining more and more attention, but the FDA has not released any more regulations or ways to market these products to the public.
Steve Minster has also stated that while the majority of CBD supplements aren’t dangerous, but some companies have been producing CBD products that are poorly manufactured, labeled wrong, or even altered. These can pose a dangerous threat to people who use the products regularly. Minster also stated that once the FDA allows CBD to come to the market, and be marketed accordingly legally, the FDA can begin enforcing those regulations.
Steve Minster has also stated how “FDA has represented that it has been actively exploring the use of this statutory authority to legalize CBD as a dietary supplement ingredient. One year ago, on May 31, 2019, FDA held a widely attended public meeting with the goal of better understanding hemp-derived substances, such as CBD, and how they should be regulated. Over a year after that meeting, FDA has taken no steps to create a legal pathway for CBD use in dietary supplements, other than making vague statements that the Agency is “actively evaluating potential rulemaking to allow CBD in dietary supplements.”
Minster stated how even a year ago the FDA had held a public meeting with the goal of understanding hemp-derived substances and how these products should be regulated.
FDA Disclaimer – These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or prior to using any CBD products.